Aaron G.L. Fletcher Cognition Therapeutics Inc (CGTX) insider trading activity

Aaron G.L. Fletcher is Director of COGNITION THERAPEUTICS INC. Currently has a direct ownership of 56,229 shares of CGTX, which is worth approximately $100,649. The most recent transaction as insider was on Sep 19, 2025, when has been sold 7,729 shares (Common Stock) at a price of $0.84 per share, resulting in proceeds of $6,492. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.2K

15.94% 3M change

287.79% 12M change

Total Value Held $100,649

Aaron G.L. Fletcher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 19 2025	BUY Exercise of conversion of derivative security	$6,492 $0.84 p/Share	7,729 Added 12.08%	56,229 Common Stock
Jun 18 2025	BUY Grant, award, or other acquisition	-	34,000 Added 41.21%	48,500 Common Stock
Jun 07 2024	BUY Grant, award, or other acquisition	-	8,500 Added 36.96%	14,500 Common Stock
Jun 09 2023	BUY Grant, award, or other acquisition	-	6,000 Added 50.0%	6,000 Common Stock

Also insider at

SWKH

SWK Holdings Corp Financial Services

Director

TFFP

TFF Pharmaceuticals, Inc. Healthcare

Director

CUE

Cue Biopharma, Inc. Healthcare

Director

INAB

IN8BIO, INC. Healthcare

> 10% Shareholder

LTRN

Lantern Pharma Inc. Healthcare

> 10% Shareholder

AZTR

Azitra Inc

> 10% Shareholder

ACTU

ACTUATE THERAPEUTICS, INC.

Director

AGF